Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus
Sunghwan Suh (Suh S), Mi Yeon Kim (Kim MY), Soo Kyoung Kim (Kim SK), Kyu Yeon Hur (Hur KY), Mi Kyoung Park (Park MK), Duk Kyu Kim (Kim DK), Nam H. Cho (Cho NH), Moon-Kyu Lee (Lee MK)
Endocrinol Metab. 2016;31(1):134-141.   Published online 2016 Mar 16     DOI: https://doi.org/10.3803/EnM.2016.31.1.134
Citations to this article as recorded by Crossref logo
Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
Fei Yang, Shan Dang, Hongjun LV, Bingyin Shi
Journal of International Medical Research.2021; 49(1): 030006052098566.     CrossRef
Elevated levels of fasting serum GIP may be protective factors for diabetic retinopathy in type 2 diabetes mellitus
LingHong Huang, JingXiong Zhou, Bo Liang, HuiBin Huang, LiangYi Li
International Journal of Diabetes in Developing Countries.2021;[Epub]     CrossRef
Enteroendocrine K and L cells in healthy and type 2 diabetic individuals
Tina Jorsal, Nicolai A. Rhee, Jens Pedersen, Camilla D. Wahlgren, Brynjulf Mortensen, Sara L. Jepsen, Jacob Jelsing, Louise S. Dalbøge, Peter Vilmann, Hazem Hassan, Jakob W. Hendel, Steen S. Poulsen, Jens J. Holst, Tina Vilsbøll, Filip K. Knop
Diabetologia.2018; 61(2): 284.     CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef